In this enlightening episode of “Let’s Be Blunt with Montel,” we are zooming in on the realm of cannabis testing and how innovative solutions
are helping the industry evolve safely and efficiently. Join host Montel Williams as he sits down with Dr. Nathan Johnson, Ph.D., the President and CEO of Verne Bio. With an impressive background spanning microbiology, molecular biology, and bioinformatics,
Nathan has been a pioneer in developing cutting-edge testing solutions for cannabis and hemp.
Key Discussions in This Episode:
Introduction to Verne Bio: Discover how Dr. Nathan Johnson found his way into the cannabis industry and the fascinating story behind
the creation of Verne Bio.
Unique Solutions: Learn about Verne Bio’s mission and the unique testing solutions they offer that transform the cannabis and hemp
industry, especially for small-scale farmers.
Innovations: Gain insights into the i-Test kit, its convenience, efficiency, and the challenges faced during its development.
AI in Testing: Understand how Verne Bio leverages artificial intelligence to improve testing accuracy and efficiency.
Future Developments: Get a sneak peek into new innovations and products currently in development at Verne Bio.
Reliability and Consistency: Hear about the measures taken to ensure the reliability and consistency of results from Verne Bio’s
testing services.
Sustainability Practices: Discuss the importance of sustainability in their testing solutions and practices.
Support for Farmers: Learn how Verne Bio supports farmers and the broader industry beyond just technology.
Education and Success Stories: Explore the role of education in helping farmers understand and implement new technologies and hear
success stories from farmers who have used Verne Bio’s solutions.
Industry Challenges and Opportunities: Reflect on the challenges Verne Bio has faced and the opportunities Dr. Johnson sees on the
horizon.
Changing Perceptions: Delve into how the perception of cannabis and hemp testing has changed within the industry in recent years.
Remember, the key to success in this industry is staying informed and adapting to changes. Until next time, stay curious and keep the conversation going.
Tune in to this episode for an in-depth look at the future of cannabis testing and how innovative solutions are paving the way for a safer,
more efficient industry.
The second section or B Block of Weed Talk News with Alaina Pinto. Florida Governor Ron DeSantis sends an unpopular message to his state’s medical patient’s threatening a supply issue if adult use passed in the fall. Karen Black reports on Arizona picking up another unionized cannabis operation. Claudia Post on Pennsylvania getting back in the race for the 25th adult use legal state? Matthew Friedlander in Washington State; and Harry Bernstein in Ohio who reports on the the legal adult use market ready to open!
In this episode of Let’s Be Blunt, Montel speaks with Dr Bonni Goldstein about her new book,
“Cannabis Is Medicine: How Medical Cannabis and CBD Are Healing Everything from Anxiety to Chronic Pain”. Dr Goldstein is one of the most respected and experienced medical cannabis physicians worldwide. She has lectured both nationally and internationally about her clinical experience and helps to educate healthcare professionals on how cannabinoids can be incorporated into a patient’s medication regimen. She is the owner and medical director of Canna-Centers Wellness & Education and the medical advisor to Weedmaps.com.
#420 #cannabis #health #cannabiscommunity #weed #cannabiseducation #cannabisculture
The C Block or final section of Weed Talk News with Alaina Pinto. PCM Founder Jimmy Young with the Bay State report; Jill Goldsberry in NJ on NYC assault by Honeysuckle magazine founders; Amie Carter in Michigan; Introducing the Shakeman, Kevin Shakir in Arkansas; Plus the Portland Pickles of the West coast independent baseball league started to sell THC infused beverages at games, the first to openly normalize the practice boosting the future of the beverage part of the industry. Plus Doug Miller’s High on Wall Street profile of publicly traded cannabis stocks and Debi Facey with her Canadian “strain” of the week